AKAN Akanda Corp.

5

Healthcare [ 5/11 ] | Drug Manufacturers—Specialty & Generic [ 31/112 ]

GB | NASDAQ | Stock

Price
$0.7134
Decreased by -0.13%
Dollar Volume (20D)
2.31 M
ADR%
21.42
Earnings Report Date (estimate)
May 1, 23 (N/A)
Market Cap.
2.77 M
Shares Float
2.41 M
Shares Outstanding
3.88 M
Beta
0.00
Price / Earnings
-0.28
BPR
2.05
20D Range
0.71 2.70
50D Range
0.71 2.70
200D Range
0.71 12.39
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 21 24.07 K - -3.08 M -
Decreased by -12.81 K%
-
Sep 30, 21 13.42 K - -3.56 M -
Decreased by -26.49 K%
-
Dec 31, 20 274.00 - 586.02 K -
Increased by +213.88 K%
-
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.